Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  

Access 360

Provided by: AstraZeneca Pharmaceuticals

Access 360
One Medimmune Way
Gaitherburg, MD 20878

TEL: 844-275-2360

FAX: 844-329-2360
Languages Spoken:

English, Spanish

Program Website


Patient Assistance Applications

Access 360 Enrollment: Contact program


Brand Name Medications Covered

  • Calquence
  • Lumoxiti
  • Faslodex
  • Lynparza
  • Imfinzi
  • Synagis
  • Iressa
  • Tagrisso

Generic Name

  • acalabrutinib
  • moxetumomab pasudotox-tdfk
  • durvalumab
  • olaparib
  • fulvestrant
  • osimertinib
  • gefitinib
  • palivizumab

Eligibility Requirements   

Insurance Status Determined case by case
Those with Part D Eligible? Determined case by case
Income Varies. *See below for details
Diagnosis/Medical Criteria Not specified
US Residency Required? Yes, or have green card or work visa


Obtaining Anyone can enroll online
Receiving Faxed, mailed or complete online
Returning Fax or mail from Doctor's office
Doctor's Action Varies
Applicant's Action Complete section, sign, attach required documents
Decision Communicated Not specified
Decision Timeframe Not specified


Amount/Supply Not specified
Sent To Not specified
Delivery Time Not specified
Refill Process Not specified
Limit Not specified
Re-application Not specified

Additional Information

Access 360 can help identify patient-specific coverage for AstraZeneca medicines. The representatives can create an in-depth report identifying the patient's full coverage and out-of-pocket costs for medical, pharmacy, and home health benefits related to AstraZeneca products.

Contact program for more details:

Updated October 02, 2018